| 3/22/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS FOR USE IN RECOGNIZED CLINICAL TRIALS (IN MEASURED DOSES) (ROW4 NOE-101 2.5 MG BC BKLT LBLD NOE-TSC-201) | 7 | SET | 920 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/4/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE-BLIND) CLINICAL TRIAL KITS (IN METERED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (KIT FOR PTG-300-11 FG CONTAINING RUSFERTIDE 60MG OR MATCHING PLACEBO) | 32 | SET | 2986 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/6/2024 | 300693000000 | PLACEBOAS AND BLINDED (OR DOUBLE-BLIND) CLINICAL TRIAL KITS (IN METERED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (IN NOE-101 3MG BC LBLD NOE-TGN-201) | 38 | SET | 5518 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/26/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN METERED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (KIT FOR PTG-300-11 FG CONTAINING RUSFERTIDE 45MG OR MATCHING PLACEBO) | 84 | SET | 7346 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/6/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE-BLIND) CLINICAL TRIAL KITS (IN METERED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (NOE-101 3.5 MG BC BKLT2 LBLD NOE-TGN-201) | 31 | SET | 4525 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/18/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (ONE SINGLE-USE VIAL OF HLX10 OR PLACEBO CONCENTRATE FOR SOLUTION FOR INFUSION CONCENTRATION 10MG/ML VOLUME:10MLFOR INTRAVEN) | 79 | SET | 683 | N/A | PSI CRO FARMA DESTEK HİZMETLERİ LİMİTED ŞİRKETİ |
| 3/12/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (KIT WITH 1 VIAL OF NAMILUMAB (KIN-1901) 150MG/ML PLACEBO) | 4 | SET | 489 | N/A | FORTREA TURKEY KLİNİK ARAŞTIRMA LİMİTED ŞİRKETİ |
| 3/6/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE-BLIND) CLINICAL TRIAL KITS (IN METERED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (NOE-101 PBO MG BC LBLD NOE-TGN-201) | 61 | SET | 6055 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/4/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (LABELLED BOTTLE CONTAINING 34X PLACEBO TO MATCH A4250 200MCG OR 600 MCG CAPSULE (SIZE 0) FOR PROTOCOL A4250-01 1 ) | 200 | SET | 19721 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/22/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE-BLIND) CLINICAL TRIAL KITS (IN METERED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (ROW4 NOE-101 PBO BC BKLT LBLD NOE-TSC-201) | 20 | SET | 2139 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |